prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Sumical. CLINICAL HISTORY: Left breast mass. FNA positive for CA. GROSS EXAMINATION: A. "Left breast biopsy, short superior, long lateral". gross consult, received. fresh. Received is 83 grams of fatty tissue (7.5 x 7 x 3 cm) which contains a. 1.5 x 1.5 x 1.3 cm firm white stellate mass. A short suture designates the. superior and a long suture the lateral margin. The deep margin is inked blue,. superior black, and inferior red. The firm mass is 0.8 cm from its closest. margin (the superior-inferior border on the anterior surface) and 1 cm its. next nearest margin, the deep margin. Lateral to the mass and distinct from. it is a region of extensive rubbery, white fibrous tissue. A portion of the. mass is submitted for ER/PR. The entire tumor and its surrounding tissue, and. representative sections of the fibrous region are submitted sequentially from. medial to lateral in Blocks A1-A14, with the tumor in Blocks A2-A8. Dr. with Dr. INTRA OPERATIVE CONSULTATION: A. "Left breast biopsy", (gross consult) : 0.8 cm from closest resection. margin, at the superior-inferior border on the anterior surface. 1 cm from. deep margin. DIAGNOSIS: A. "LEFT BREAST BIOPSY" (EXCISIONAL BIOPSY) : INFILTRATING DUCTAL CARCINOMA. N.S.A.B.P. HISTOLOGIC GRADE: 2 OF 3. N.S.A.B.P. NUCLEAR GRADE: 2 OF 3. GROSS TUMOR SIZE: 1.6 CM. IN-SITU CARCINOMA, PRESENT: OCCUPYING LESS THAN 10% OF TUMOR VOLUME. TYPE OF IN SITU CARCINOMA: SOLID AND CRIBRIFORM. LYMPHATIC/VASCULAR INVASION: NOT UNEQUIVOCALLY PRESENT. SURGICAL MARGIN STATUS: NEGATIVE. STATUS OF UNINVOLVED BREAST TISSUE: MILD FIBROCYSTIC CHANGE. ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING: YES. METHODOLOGY: FRESH TISSUE. RESULTS WILL BE ISSUED IN AN ADDENDUM. M.D. Pager-. ADDENDUM 1: Tissue was sent to the. for assay of the estrogen. and. progesterone receptors. The estrogen receptor activity was judged as. positive with an estimated FMOL value of 39. The progesterone receptor. activity was judged as negative with an estimated FMOL value of 0. Please. refer to. for a complete report. M.D. Pager#.

expanded version (tokens=990) : 
 The pathology report indicates that the patient has luminal A subtype breast cancer with a Sumical score. The report also mentions that there was a left breast mass, and a fine needle aspiration confirmed the presence of cancer cells. The tumor size is measured at 1.6 cm, with infiltrating ductal carcinoma as the diagnosis. 

The histologic grade of the cancer is 2 of 3, while the nuclear grade is also 2 of 3. There is also in-situ carcinoma which occupies less than 10% of the tumor volume, with a solid and cribiform type of in situ carcinoma. The report suggests that there is no lymphatic or vascular invasion in this case. 

The surgical margin status is negative, indicating that there are no cancer cells found in the surrounding tissue. The pathology report also notes that there is mild fibrocystic change in the uninvolved breast tissue. 

The receptor status of the tumor was pending and thus was sent for assay of estrogen and progesterone receptors. The estrogen receptor activity was positive with an estimated FMOL value of 39, while the progesterone receptor activity was negative with an estimated FMOL value of 0. Additional information regarding the results of estrogen, progesterone receptor activity and cell cycle analysis would be reported in an addendum.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1133) : 
 Left breast cancer biopsy confirmed infiltrating ductal carcinoma with luminal A subtype and Sumical score. Histological grade is 2 of 3, nuclear grade is also 2 of 3. In-situ carcinoma occupies less than 10% of the tumor volume. No lymphatic or vascular invasion was seen, and surgical margin status is negative. Estrogen receptor activity shows positive results while progesterone activity is negative, with precise values noted in the addendum.

